CN Patent

CN103764119A — 包含纳洛酮的鼻内药物剂型

Assigned to Euro Celtique SA · Expires 2014-04-30 · 12y expired

What this patent protects

本发明涉及鼻内药物剂型，其包含剂量单元，所述剂量单元包含溶于≤250μl体积施用流体中的相当于≥0.5mg盐酸纳洛酮之量的纳洛酮或其可药用盐。本发明还涉及这样的鼻内药物剂型，其用于治疗阿片样物质过量给药和/或其至少一种症状。

USPTO Abstract

本发明涉及鼻内药物剂型，其包含剂量单元，所述剂量单元包含溶于≤250μl体积施用流体中的相当于≥0.5mg盐酸纳洛酮之量的纳洛酮或其可药用盐。本发明还涉及这样的鼻内药物剂型，其用于治疗阿片样物质过量给药和/或其至少一种症状。

Drugs covered by this patent

Patent Metadata

Patent number
CN103764119A
Jurisdiction
CN
Classification
—
Expires
2014-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Euro Celtique SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.